US Patent Issued to MIRATI THERAPEUTICS on July 29 for "Substituted imidazo[1,2-cpyrimidines as PRC2 inhibitors" (California Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,435, issued on July 29, was assigned to MIRATI THERAPEUTICS INC. (Princeton, N.J.).

"Substituted imidazo[1,2-cpyrimidines as PRC2 inhibitors" was invented by Matthew Arnold Marx (San Diego), Matthew Randolph Lee (Del Mar, Calif.), Thomas P. Bobinski (San Diego), Aaron Craig Burns (San Diego), Nidhi Arora (San Diego), James Gail Christensen (San Diego) and John Michael Ketcham (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a process for the preparation of a compound of Formula (G), comprising reacting a compound of Formula (H) with a compound of Formula (D) in the presence of a palladium catalyst to afford ...